Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Thyroid hormone replacement in hypothyroid adults with type 2 diabetes
NL-OMON39459Phase 4Recruiting
- Sponsor
- Maastricht University
- Start
- Jul 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of levothyroxine sodium in hypothyroidism and type 2 diabetes mellitus (T2DM) (2 cohorts), sponsored by Maastricht University. Primary endpoints: Change in insulin sensitivity, Change in skeletal muscle mitochondrial function and 1 more. Started Jul 2011; status: recruiting.
02
Drugs
levothyroxine sodium
03
Conditions
hypothyroidismtype 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NL-OMON39459.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON39459.